Advisory Board May 3, 2022

Rae Woods:

From Advisory Board, we’re bringing you a Radio Advisory. My name is Rachel Woods. You can call me Rae. Today, I want to talk about the life sciences part of the healthcare industry. You may think of these as just the drug makers or just the device companies. But in reality, there is a critical way that life sciences interacts with the rest of the healthcare ecosystem. And that’s evidence. So to talk about the evolving role of evidence, I’ve brought three guests. We’ve got life sciences experts, Solomon Banjo and Pam Divack. We’ve also got Lou Brooks, SVP from Optum Life Sciences. Well, welcome to Radio Advisory to all three of you, Pam, Solomon, Lou. It’s been...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Big Data, Biotechnology, Conferences / Podcast, Pharma / Biotech, Technology, Trends
Gene Therapy for Cardiomyopathies Presents Promising Alternative to Current Treatment
STAT+: 3 trends to watch in biotech in 2025
The GLP-1 dilemma persists into 2025
The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

Share This Article